Related by context. All words. (Click for frequent words.) 73 immunohistochemistry IHC 70 quantitative RT PCR 70 immunohistochemical 70 Western blot 69 immunohistochemical analysis 69 immunohistochemical staining 68 situ hybridization 68 immunostaining 68 Western blotting 67 RT PCR 66 immunofluorescence 66 enzyme linked immunosorbent 66 quantitative PCR 66 qRT PCR 66 reaction RT PCR 65 assay ELISA 65 Immunohistochemistry 65 immunoblotting 64 PCR assay 64 breast carcinomas 64 multiplex PCR 64 reverse transcription polymerase 64 immunofluorescent 64 gene amplification 64 reverse transcriptase polymerase chain 63 thyroglobulin 63 RQ PCR 63 urine cytology 63 peripheral blood mononuclear 63 ELISpot 63 micrometastasis 63 RT qPCR 63 array CGH 63 ELISA 62 situ hybridisation 62 immunocytochemistry 62 estrogen receptor ER 62 mRNA expression 62 tissue microarray 62 histopathologic 62 Immunohistochemical staining 62 nested PCR 61 ERBB2 61 cytokeratin 61 microarray analysis 61 epithelial tumors 61 situ hybridization FISH 61 histopathology 61 quantitative reverse transcriptase 60 HER2 60 FISH fluorescence 60 histopathological 60 gene expression profiling 60 chromatin immunoprecipitation 60 Immunohistochemical 60 RT PCR assay 60 nucleic acid amplification 60 Her2/neu 60 F FDG PET 60 MTT assay 60 prognostic markers 60 FDG PET 59 hematoxylin 59 histology 59 synovial tissue 59 TMPRSS2 ERG 59 histologic 59 Clusterin 59 karyotyping 59 breast carcinoma 59 cytologic 59 massively parallel sequencing 59 Immunohistochemical analysis 59 oligonucleotide microarray 59 immunofluorescence microscopy 59 cell lysates 59 immunoblot 59 immunoprecipitation 59 fine needle aspiration 59 cytological 59 Western Blot 59 lymph node metastases 59 histopathologic examination 59 promoter methylation 59 formalin fixed paraffin embedded 59 polymerase chain reaction 59 reaction PCR 58 quantitative PCR qPCR 58 vimentin 58 ELISPOT 58 microRNA expression 58 biopsy specimens 58 PCa 58 NMP# 58 ELISA assay 58 lysates 58 VEGF expression 58 annexin V 58 sentinel lymph node 58 K ras mutations 58 proteomic analysis 58 comparative genomic hybridization 58 FDG uptake 58 EUS FNA 58 semiquantitative 58 FDG-PET/CT 58 lymph node metastasis 58 sentinel lymph node biopsy 58 miRNA expression 58 malignant lesions 58 single nucleotide polymorphism 58 transcriptional profiling 58 FFPE 57 lymphovascular invasion 57 pelvic ultrasound 57 immunoreactivity 57 xenografts 57 tumor biopsies 57 flow cytometry 57 #F FDG PET 57 microsatellite instability 57 cytology 57 methylated DNA 57 FLT3 57 bioluminescence imaging 57 supernatants 57 carcinoembryonic antigen 57 Lymph node 57 KRAS mutation 57 brightfield microscopy 57 Immunohistochemistry IHC 57 indirect immunofluorescence 57 NGAL 57 biomarker 57 tumorigenicity 57 microarrays 57 ELISAs 57 eosin 57 Annexin V 57 axillary lymph node 57 CyPath ® assay 57 apolipoproteins 57 Ki# 57 induced sputum 57 histological 57 differentially expressed proteins 57 prognostic marker 57 quantitative polymerase chain 57 array comparative genomic 57 Histologic 57 genomic profiling 57 genotyping assay 57 chromosomal aberrations 57 biochemical assays 57 prognostic factor 56 somatic mutations 56 ultrasonography 56 prognostic biomarker 56 shRNAs 56 alkaline phosphatase ALP 56 IgG antibodies 56 histologically 56 transfection 56 serological tests 56 biopsies 56 HLA typing 56 prostate carcinoma 56 cell lysate 56 chromatin immunoprecipitation ChIP 56 CIN2 + 56 NPM1 mutations 56 RRM1 56 microarray 56 SNP rs# [001] 56 ChIP 56 Cervista HPV HR 56 morphometry 56 WT1 56 transgene expression 56 scintigraphic 56 BCR ABL 56 NPM1 56 gene expression profiles 56 PCR amplification 56 #F FDG 56 distant metastasis 56 TNFa 56 microarray experiments 56 BRAF mutation 56 Sanger sequencing 56 SDS PAGE 56 cDNA libraries 56 toluidine blue 56 cTnI 56 xenograft models 56 hypermethylated 56 Gram stain 56 ImmuKnow 56 sentinel lymph nodes 56 cytogenetic 56 fluorescence microscopes 56 RECIST Response Evaluation Criteria 56 immunochemical 56 qPCR 56 proteomic 56 endoglin 56 Microarray analysis 56 vitro assay 56 constitutively active 56 bone scintigraphy 56 transfected cells 56 mucinous 56 Immunofluorescence 56 sensitivity specificity 55 histologic diagnosis 55 HER2 amplification 55 ChIP Seq 55 haplotyping 55 TIMP 55 genomic alterations 55 flow cytometric 55 HER2 overexpression 55 #S rDNA 55 CD# expression [001] 55 predictive biomarker 55 CD#b 55 malignant nodules 55 ChIP chip 55 HepG2 cells 55 urothelial carcinoma 55 SLNB 55 uPAR 55 biopsied tissue 55 ChIP seq 55 p# mitogen activated 55 CISH 55 Doppler sonography 55 mutational analysis 55 Alkaline Phosphatase 55 transcriptional regulation 55 QPCR 55 rs# [002] 55 TRUS 55 isoform 55 #S rRNA gene 55 myelofibrosis polycythemia vera 55 histopathological examination 55 ERK1 2 55 biopsy 55 multiparametric 55 Polymerase Chain Reaction 55 syngeneic 55 colorectal carcinoma 55 D dimer 55 miRview ™ squamous 55 cardiac troponin T 55 NPM1 mutation 55 AlloMap 55 fluorescein angiography 55 serologic 55 PFGE 55 molecular assays 55 K ras 55 liver biopsy 55 prostate cancer CaP 55 sentinel node 55 transcriptomic 55 bioluminescent imaging 55 radionuclide imaging 55 PBMCs 55 HAAH 55 HER2/neu 55 histone modifications 55 catheter angiography 55 viral nucleic acids 55 genomic DNA 55 probe amplification MLPA 55 Her2 55 urine dipstick 55 adenoviral 55 perfusion MRI 55 PET CT scans 55 splice variant 55 ex vivo 55 neoadjuvant chemotherapy 55 multiplex ligation dependent 55 luciferase reporter 55 cDNA 55 prostate epithelial cells 55 preoperative staging 55 gene expression 55 Tr DNA 55 miRview squamous 55 SLN biopsy 55 cTnT 55 molecular markers 55 DNase 55 palladin 54 CD#c 54 enzyme immunoassay 54 sarcosine 54 multiplexed assays 54 cytogenetics 54 mesothelin 54 transcriptome analysis 54 bladder tumors 54 HER2 gene 54 diagnostic biomarker 54 progesterone receptor PR 54 histologic examination 54 ELISA assays 54 transesophageal echocardiography 54 excisional biopsy 54 quantitative cytology 54 HERmark 54 #S rRNA 54 bronchoalveolar lavage 54 confocal microscopy 54 Cytogenetic 54 MUC1 protein 54 Lp PLA 2 54 estrogen receptor progesterone receptor 54 affinity purification 54 gene expression patterns 54 pathologic examination 54 cell lysis 54 malignant prostate 54 optical coherence tomography OCT 54 nodal dissection 54 scintigraphy 54 GSTP1 54 mediastinoscopy 54 Quantitative RT PCR 54 transfected 54 IGF IR 54 core needle biopsy 54 FGFR3 54 EpCAM 54 genotyping 54 p# MAPK 54 tandem mass spectrometry 54 bisulfite sequencing 54 biochemical marker 54 HER2 negative 54 MLH1 54 SPINK1 54 caveolin 1 54 proteomic analyzes 54 virulence genes 54 pDCs 54 IgG antibody 54 renal tumors 54 HER2 receptor 54 DCE MRI 54 tissue microarrays 54 progesterone receptor 54 overexpression 54 proteolytic cleavage 54 chest radiographs 54 CT angiography 54 mutational status 54 Jurkat cells 54 EGFP 54 Gamma Imaging BSGI 54 ABL1 54 oligonucleotide microarrays 54 zebrafish embryos 54 cDNA microarray 54 hamartomas 54 splice variants 54 malignant transformation 54 histopathologic diagnosis 54 estrogen receptor 54 transduced 54 paraffin embedded tissue 54 GRP# 54 tissue biopsies 54 putative biomarkers 54 PDGF B 54 activin 54 glycosylation 54 cryo electron microscopy 54 ELISPOT assay 54 trophoblasts 54 core needle biopsies 54 HER-2/neu 54 transurethral resection 54 D Dimer 54 Genotyping 54 Chemokine Receptor 54 MR spectroscopy 54 prostate cancer PCa 54 siRNA knockdown 54 gastric adenocarcinoma 54 T#I [002] 54 cytotoxicity assays 54 miRview mets 54 T SPOT.TB 54 ductal carcinomas 54 urinary cytology 54 UGT#A# 54 cellularity 54 FCGR3A 54 differentially expressed genes 54 Septin9 54 gene expression microarrays 54 poly ADP ribose polymerase 54 mycobacterial 54 PCR RFLP 54 EGFRvIII 54 QRT PCR 54 microscopy techniques 54 molecular biomarkers 54 vivo 54 Sanger Sequencing 54 E#F# 54 amyloid deposition 54 chemiluminescence 54 CEACAM1 54 duplex ultrasonography 54 HIV1 54 noninvasive imaging 54 univariate 54 cells PBMCs 54 chemosensitivity 54 stably transfected 54 fetal echocardiography 54 ultrasound elastography 54 Microarray 54 cardiac magnetic resonance 53 gel electrophoresis 53 ANOVA 53 MSH2 53 N glycan 53 troponins 53 TNFalpha 53 grade cervical intraepithelial 53 hTERT 53 TIMP 1 53 mononuclear cells 53 colorectal adenocarcinoma 53 homogenates 53 ptau 53 p# antigen 53 MDA MB 53 ultrasonographic 53 papillary RCC 53 Positron emission tomography PET 53 HGPIN 53 axillary lymph nodes 53 gastric carcinomas 53 Flow cytometry 53 β1 53 sequence homology 53 hematopoietic progenitor cells 53 MAPK pathway 53 C1q 53 TNF α 53 Affymetrix GeneChip ® 53 paraffin embedded 53 IL 1β 53 cytotoxicity 53 pCR 53 CHO cells 53 p tau 53 lentiviral 53 iTRAQ 53 bispecific antibody 53 electron microscopy 53 transgenic rats 53 nucleotide variations 53 HER2 expression 53 IL #R 53 ultrastructural 53 imatinib therapy 53 vitro experiments 53 ZNF# 53 constitutively expressed 53 RNA transcripts 53 hypermethylation 53 EGFR mutation 53 Western Blotting 53 inhibin 53 cystatin C 53 serum thyroglobulin 53 Fine needle aspiration 53 cerebrospinal fluid CSF 53 IgM 53 5alpha reductase 53 vitro studies 53 missense mutation 53 DNA methylation patterns 53 MR imaging 53 cultured cells 53 nucleic acid assays 53 tumoral 53 pancreatic adenocarcinoma 53 EGFR 53 nodal metastases 53 microglial 53 IGF 1R 53 Histopathologic 53 IL#B 53 biotinylated 53 surgical biopsy 53 PITX2 53 lysate 53 capillary electrophoresis 53 micrometastases 53 aCGH 53 RNase L 53 phenotyping 53 tumor necrosis 53 glycan 53 microRNA profiling 53 bDNA 53 enzyme immunoassay EIA 53 EGFR receptor 53 hepatocellular carcinomas 53 LRAT 53 CaP 53 proto oncogene 53 K RAS 53 PCR assays 53 radioimmunoassay 53 lymphadenectomy 53 pT2 53 prognostically 53 lymphocytosis 53 maternal serum 53 antibody mediated 53 COL#A# 53 IDH1 mutation 53 epithelial ovarian cancer 53 undifferentiated hESCs 53 serum biomarkers 53 mediastinal lymph nodes 53 heterodimers 53 histologic subtypes 53 HBsAg 53 intestinal biopsy 53 Situ Hybridization 53 TaqMan 53 transthoracic 53 myeloperoxidase 53 EGF receptors 53 heterologous expression 53 clusterin 53 DHPLC 53 viral tropism 53 pT3 53 mammographically 53 PET imaging 53 PrPSc 53 Situ Hybridization FISH 53 rheumatoid factor 53 colon carcinoma 53 Histopathology 53 prognostic indicator 53 assay 53 Neisseria gonorrhoeae 53 ALK mutations 53 PCA3 53 phylogenetic analyzes 53 hybridoma 53 TaqMan R 53 DNMT1 53 Histological 53 DNA methylation 53 guaiac 53 ELISA enzyme 53 specific antigen PSA 53 NMIBC 53 colorectal tumor 53 needle biopsy 53 fetal aneuploidy 53 gene polymorphisms 53 sentinel node biopsy 53 EGF receptor 53 MGMT gene 53 steroidogenesis 53 BRAF V#E mutation 53 TAp# 53 peroxidase 53 ERCC1 53 cervical carcinoma 53 methylation 53 P selectin 53 missense mutations 53 endometrial biopsy 53 tryptase 53 methylation markers 53 CXCR4 53 Tie2 53 cholera toxin 53 hSBA 53 nomogram 53 UsiRNAs 53 serological 53 biodistribution studies 53 hydroxylase 53 flavopiridol 53 gene rearrangements 53 precursor lesions 53 #T# L1 53 plain radiographs 53 lipoxygenase 53 specific antigen 53 Polymerase Chain Reaction PCR 53 HLA genotyping 53 LC-MS/MS 53 FasL 53 lactate dehydrogenase LDH 53 tumor xenografts 53 coding genes 53 renal carcinoma 53 protein electrophoresis 53 vivo potency 52 quantitation 52 biomarker identification 52 deacetylase 52 selective inhibition 52 detecting colorectal cancer 52 transcription PCR 52 agarose gel electrophoresis 52 DIGE 52 Rosetta Genomics microRNA 52 immunoglobulin genes 52 confirmatory tests 52 phosphoprotein 52 allelic 52 Phylogenetic analysis 52 isoenzyme 52 Cathepsin B 52 inducible nitric oxide synthase 52 bcl 2 52 subcellular localization 52 pulmonary metastases 52 Illumina GoldenGate 52 EBUS FNA 52 peptide BNP 52 sCJD 52 vitro assays 52 lobular carcinoma 52 Quantitation 52 Polymerase 52 gene rearrangement 52 Histologically 52 haematopoietic 52 Flt3 52 Hedgehog inhibitor 52 ultrastructure 52 intraobserver 52 endometrial adenocarcinoma 52 osteogenic 52 pretargeting 52 IL 1beta 52 HER2 neu 52 thymosin 52 Cytochrome P# 52 HTRF R 52 thyroid stimulating hormone 52 B7 H3 52 murine model 52 intact parathyroid hormone 52 intravesical therapy 52 optical coherence tomography 52 microarray gene expression 52 atypia 52 ErbB2 52 antigen 52 neoadjuvant 52 PSADT 52 #m Tc 52 APTIMA HPV 52 P cadherin 52 xenograft tumors 52 transgenic mice 52 IgM antibody 52 miRview TM mets 52 CTNNB1 52 nonviral 52 angiographically 52 intestinal metaplasia 52 EBUS 52 TTR gene 52 biopsy specimen 52 neural progenitor cells 52 transcriptome sequencing 52 florbetaben 52 RNA sequencing 52 NSCLC tumors 52 prognostic significance 52 pathologic 52 lymphoid cells 52 hepatoma 52 karyotype 52 quantitative trait loci 52 miRNA profiling 52 RNA splicing 52 beta1 integrin 52 deoxyglucose 52 MEFs 52 enzymatic activity 52 lymphatic mapping 52 axillary dissection 52 endometrioid 52 substrate specificity 52 activating mutation 52 esophageal carcinoma 52 pleural fluid 52 cytokine secretion 52 orthologs 52 breast cancer subtypes 52 Syk 52 BALB c mice 52 epitope 52 assay detects 52 EGFR HER 52 MammaPrint R 52 genetic biomarkers 52 fine needle aspirate 52 5 hmC 52 genotype 52 cytologic examination 52 ligand induced 52 magnetic resonance spectroscopy MRS 52 HDACi 52 adipogenic 52 metaplasia 52 TUNEL 52 transabdominal 52 PC# cells 52 matrix metalloproteinases 52 cardiac troponin 52 RNA sequences 52 invasive carcinomas 52 contralateral breast 52 Oncogenic 52 biomarkers 52 FGFR1 52 JAK2 V#F 52 microRNA biomarkers 52 microdissected 52 Haplotype 52 apoE 52 sonographic findings 52 Roche AmpliChip 52 S#A# [002] 52 ovarian carcinoma 52 multidetector CT 52 orthotopic 52 vitro 52 perfusion imaging 52 index assay IVDMIA 52 ENMD # 52 TMPRSS2 ERG fusion 52 myocardial necrosis 52 Recurrence Score 52 squamous intraepithelial lesions 52 PALB2 52 FFPE tissues 52 ovarian tumor 52 autoantibodies 52 PDGF receptor 52 molecular profiling 52 T1 weighted 52 cDNAs 52 EGFR expression 52 MALDI MS 52 positron emission 52 ASCUS 52 antigenic epitopes 52 exonuclease 52 immunochemical fecal occult 52 monoclonal 52 miRview meso 52 MMP# 52 seronegative 52 operable breast cancer 52 metastatic lesion 52 serous ovarian cancer 52 protein quantitation 52 MGd 52 genomewide 52 isotypes 52 lung fibroblasts 52 replicase 52 Circulating tumor cells 52 Raman spectroscopic 52 prostate abnormalities 52 gene loci 52 thymidine kinase 52 antibody antigen 52 coronary arteriography 52 automated microscopy 52 multiplex assay 52 endoscopic ultrasound 52 troponin assay 52 TLR3 52 colposcopy 52 p# INK4a 52 iNOS 52 lymph node dissection 52 Mass Spectrometry MS 52 lymphocyte proliferation 52 herpesviruses 52 sentinel nodes 52 tumor suppressor gene 52 E. faecalis 52 pharmacodynamic biomarkers 52 Genotypes 52 HEK# cells 52 fluorescently labeled 52 hematopoietic cells 52 neutralizing antibody responses 52 c MYC 52 MALDI TOF MS 52 VE cadherin 52 papillary thyroid carcinoma 52 nucleotide substitutions 52 nodal metastasis 52 thymidine 52 potently inhibited 52 PTEN gene 52 quantitative gene expression 52 P. gingivalis 52 Biopsies 52 Epidermal Growth Factor Receptor 52 KLF4 52 DNA microarray 52 SPECT imaging 52 genome microarray 52 CagA 52 HLA DQ2 52 homodimer 52 morphologic 52 B CLL 51 HER2 positive cancers 51 VeraCode 51 cell adhesion molecule 51 miRNA 51 overexpressing 51 protein biomarkers 51 liver fibrosis 51 SILAC 51 cytoreductive nephrectomy 51 biomarker assays 51 BRAF mutations 51 intratumoral 51 acinar 51 lactate dehydrogenase 51 Y STR 51 adenocarcinomas 51 CDK4 51 HCV replicon 51 activated lymphocytes 51 Liver biopsies 51 PIK3CA 51 quantitative proteomics 51 microdissection 51 fallopian tube cancers 51 NOD SCID mice 51 hematopoietic progenitors 51 hyperinsulinemic euglycemic clamp 51 protein biomarker 51 cytosine methylation 51 SNP genotyping 51 OncotypeDX 51 alpha fetoprotein AFP 51 liver biopsies 51 HSCT 51 MR angiography 51 HPV genotyping 51 gadolinium enhanced 51 chromosomal DNA 51 metastatic 51 flow cytometric analysis 51 thyroid carcinoma 51 invasive coronary angiography 51 antitumor effect 51 TOP2A 51 eTag assays 51 serum HCV RNA 51 ESR1 51 Nedd4 51 histopathologic findings 51 needle biopsies 51 Histological examination 51 metabolomic profiling 51 chromosomal mutations 51 Jhdm2a 51 hepatocellular carcinoma 51 HERmark assay 51 biodistribution 51 Breast Specific 51 GNAQ 51 radiolabeled 51 gastric carcinoma 51 Histopathological 51 hepatocytes 51 genes encoding 51 nomograms 51 Supplemental Figure 51 human leukocyte antigen 51 methylation patterns 51 Rab5 51 HG PIN 51 spectrophotometric 51 oligonucleotide ligation 51 clonogenic 51 VEGFR 51 CCR1 51 papillary 51 T2 weighted 51 alternatively spliced 51 phenotype 51 liver metastasis 51 VNTR 51 tumor specific antigen 51 pancreatic lung 51 microdeletions 51 cells PBMC 51 axillary nodes 51 spiral computed tomography 51 interleukin IL -# 51 CD# [002] 51 diagnostic modality 51 aggregated Abeta 51 exon 51 LHRH receptor positive 51 fluorescent microscope 51 intratumoral injection 51 GRNCM1 51 RUNX3 51 CCR7 51 CTGF 51 ES cells 51 androgen receptor AR 51 liquid chromatography tandem 51 colorimetric 51 chromosome #p#.# 51 conventional cytology 51 mitochondrial DNA mtDNA 51 Liver biopsy 51 pathologic diagnosis 51 molecular subtypes 51 NF kB pathway 51 formalin fixed 51 lymph node biopsies 51 HOXB# 51 murine 51 NFkB 51 TGF beta1 51 mouse mammary 51 PARP inhibition 51 hyperintense lesions 51 adventitia 51 alveolar epithelial cells 51 LRP5 51 diffusion tensor 51 CINtec R 51 BALB c 51 Multivariate analysis 51 mRNA transcripts 51 univariate analysis 51 Genotypic 51 gDNA 51 BCR ABL1 51 frameshift mutation 51 mutagenesis 51 IFN gamma 51 cystectomy 51 transgenic mouse models 51 genomic loci 51 MALT lymphoma 51 hierarchical clustering 51 PCR RT PCR 51 TaqMan assay 51 IL 1ß 51 glutamic acid decarboxylase 51 PCR primers 51 neoplastic cells 51 adrenocortical 51 cisplatin resistant 51 renal cell carcinomas 51 genotypic resistance 51 CLL cells 51 serological testing 51 nucleic acid sequence 51 BACcel ™ 51 prostatic adenocarcinoma 51 multiplex assays 51 Gleevec resistant 51 Kruskal Wallis test 51 gene expression biomarkers 51 x ray crystallography 51 IFN α 51 TGF ß